EllisDon has reached an agreement to serve as the construction contractor for the UHNBC Acute Care Tower Phase 1.
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...
Anumana Inc., a leader in AI-powered cardiovascular detection algorithms, today announced the appointment of Kevin Ballinger ...
Fourth quarter and Full-Year 2025 revenue are expected to be approximately $9.2 million and $37.0 million, respectively, with expected Q4 gross margins in the range ...
Pre-hospital blood helped this UAB patient beat a zero percent chance of survival, so why is it still underutilized?